A landmark study published in BMC Gastroenterology followed 29 patients with nonalcoholic fatty liver disease who received oral glutathione supplementation
DHA too was shown to stimulate PPARs [124]
Participants with normal hepatic function were eligible for inclusion if they were judged to be of general good health by the investigator, based on a medical examination (including physical examination, medical history, vital signs and ECG) and had liver enzyme levels within prespecified limits (alanine aminotransferase upper limit of normal [ULN] + 10%, aspartate aminotransferase ULN + 20% and total bilirubin ULN + 20%)
No wonder he was so handy with a crowbar
FDA alerted the public about Chinese weight-loss products, Chaso (Jianfei) Diet Capsules and Chaso Genpi, because they pose a potential public health risk
To address these limitations, we propose the use of an Actor-Network Theory (ANT) perspective